title: Pharmacist intervention in treatment of patients with genotype 1 chronic hepatitis C.
authors.affiliation: Department of Pharmacy and Pharmaceutical Technology, University of Barcelona, Faculty of Pharmacy. Av. Joan XXIII s/n, Barcelona, Spain 08028. emarino@ub.edu
authors.forename: Eduardo L
authors.initials: EL
authors.lastname: Marino
authors.forename: Luis
authors.initials: L
authors.lastname: Alvarez-Rubio
authors.forename: Silvia
authors.initials: S
authors.lastname: Miro
authors.forename: Pilar
authors.initials: P
authors.lastname: Modamio
authors.forename: Fernando
authors.initials: F
authors.lastname: Banos
authors.forename: Cecilia F
authors.initials: CF
authors.lastname: Lastra
authors.forename: Aintzane
authors.initials: A
authors.lastname: Alberdi-Leniz
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005838:Genotype; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010595:Pharmacists / Q000458:organization & administration*; D010607:Pharmacy Service, Hospital / Q000458:organization & administration*; D011092:Polyethylene Glycols; D024382:Professional Role; D011446:Prospective Studies; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use; D013030:Spain; D016896:Treatment Outcome; D016903:Drug Monitoring
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b